Erlotinib Terminated Phase 2 Trials for Neuroendocrine Tumors / Carcinoid Tumors / Neuroblastomas / Adrenal Gland Tumors / Progressive Neuroendocrine Tumors of pancreatic origin / Multiple Endocrine Neoplasia Treatment